NJ-based Johnson & Johnson says COVID-19 vaccine is safe, showing promising immune response
Johnson & Johnson says its COVID-19 vaccine is safe and showing a promising immune response.
•
Jan 14, 2021, 12:19 PM
•
Updated 1,647 days ago
Share:
More Stories
0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
313ds ago
Hometown Heroes in the Hudson Valley
360ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
505ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
526ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
653ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
653ds ago0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
313ds agoHometown Heroes in the Hudson Valley
360ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
505ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
526ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
653ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
653ds agoJohnson & Johnson says its COVID-19 vaccine is safe and
showing a promising immune response.
The company has reported few
side effects in early trials, things such as headache, muscle aches, and
soreness.
Data shows most volunteers
developed antibodies after 28 days.
Johnson & Johnson's
vaccine requires only one dose, while Pfizer's and Moderna's require two.
More from News 12
1:16
Parade celebrates Carmel Fire Department's 110 years of volunteer service
0:45
Spring Valley celebrates Immigrant Heritage Day
0:28
Police: Man barricaded himself in Nyack grocery store bathroom
1:43
Hartsdale’s Wig Outlet celebrates 12th anniversary with open house and hair drive
1:54
Report: More people under 50 are being diagnosed with gastrointestinal cancers
0:38
